APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human BMP-2

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Human BMP-2 Market Analysis and Forecast 2026-2032

26 December 2025200 pages

Choose your research edition.

Industry ResearchRecombinant Human BMP-2 Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human BMP-2 Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Recombinant Human BMP-2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human BMP-2 Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human BMP-2 Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Recombinant Human BMP-2 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Human BMP-2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Human BMP-2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Human BMP-2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Human BMP-2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Recombinant Human BMP-2 include 赛默飞世尔, Yeasen Biotechnology (Shanghai), Yantai Zhenghai Bio-Tech, Abbkine Scientific, WEIGAO, Shanghai Zhong Qiao Xin Zhou Biotechnology, Shanghai NovoPro, HANGZHOU JIUYUAN GENE ENGINEERIN and Beijing Baiaolaibo Technology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Recombinant Human BMP-2, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Human BMP-2, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Human BMP-2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Human BMP-2 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Human BMP-2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Human BMP-2 sales, projected growth trends, production technology, application and end-user industry.

Recombinant Human BMP-2 Segment by Company

赛默飞世尔

Yeasen Biotechnology (Shanghai)

Yantai Zhenghai Bio-Tech

Abbkine Scientific

WEIGAO

Shanghai Zhong Qiao Xin Zhou Biotechnology

Shanghai NovoPro

HANGZHOU JIUYUAN GENE ENGINEERIN

Beijing Baiaolaibo Technology

STEMCELL Technologies

Sigma Aldrich

Proteintech

CUSABIO TECHNOLOGY

Cgbio

Cell Guidance Systems

Biomol GmbH

Recombinant Human BMP-2 Segment by Type

Powder

Sponge

Others

Recombinant Human BMP-2 Segment by Application

Hospital

Research Institute

Others

Recombinant Human BMP-2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human BMP-2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human BMP-2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human BMP-2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Recombinant Human BMP-2 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Recombinant Human BMP-2 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human BMP-2 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Human BMP-2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Powder Major Manufacturers Table 3. Sponge Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Recombinant Human BMP-2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Research Institute Major Manufacturers Table 8. Others Major Manufacturers Table 9. Recombinant Human BMP-2 Industry Trends Table 10. Recombinant Human BMP-2 Industry Drivers Table 11. Recombinant Human BMP-2 Industry Opportunities and Challenges Table 12. Recombinant Human BMP-2 Industry Restraints Table 13. Global Recombinant Human BMP-2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Recombinant Human BMP-2 Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Recombinant Human BMP-2 Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Recombinant Human BMP-2 Revenue Market Share by Region (2021-2026) Table 17. Global Recombinant Human BMP-2 Revenue Market Share by Region (2027-2032) Table 18. Global Recombinant Human BMP-2 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 19. Global Recombinant Human BMP-2 Sales by Region (2021-2026) & (Kg) Table 20. Global Recombinant Human BMP-2 Sales by Region (2027-2032) & (Kg) Table 21. Global Recombinant Human BMP-2 Sales Market Share by Region (2021-2026) Table 22. Global Recombinant Human BMP-2 Sales Market Share by Region (2027-2032) Table 23. Global Recombinant Human BMP-2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Recombinant Human BMP-2 Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Recombinant Human BMP-2 Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Recombinant Human BMP-2 Sales Market Share by Manufacturers (2021-2026) Table 27. Global Recombinant Human BMP-2 Sales Price (US$/g) of Manufacturers (2021-2026) Table 28. Global Recombinant Human BMP-2 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Recombinant Human BMP-2 Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Recombinant Human BMP-2 Manufacturers, Product Type & Application Table 31. Global Recombinant Human BMP-2 Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Recombinant Human BMP-2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Recombinant Human BMP-2 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Recombinant Human BMP-2 Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Recombinant Human BMP-2 Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Recombinant Human BMP-2 Revenue Market Share by Type (2021-2026) Table 38. Global Recombinant Human BMP-2 Revenue Market Share by Type (2027-2032) Table 39. Global Recombinant Human BMP-2 Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 40. Global Recombinant Human BMP-2 Sales by Type (2021-2026) & (Kg) Table 41. Global Recombinant Human BMP-2 Sales by Type (2027-2032) & (Kg) Table 42. Global Recombinant Human BMP-2 Sales Market Share by Type (2021-2026) Table 43. Global Recombinant Human BMP-2 Sales Market Share by Type (2027-2032) Table 44. Global Recombinant Human BMP-2 Price by Type (2021-2026) & (US$/g) Table 45. Global Recombinant Human BMP-2 Price by Type (2027-2032) & (US$/g) Table 46. Global Recombinant Human BMP-2 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Recombinant Human BMP-2 Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Recombinant Human BMP-2 Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Recombinant Human BMP-2 Revenue Market Share by Application (2021-2026) Table 50. Global Recombinant Human BMP-2 Revenue Market Share by Application (2027-2032) Table 51. Global Recombinant Human BMP-2 Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 52. Global Recombinant Human BMP-2 Sales by Application (2021-2026) & (Kg) Table 53. Global Recombinant Human BMP-2 Sales by Application (2027-2032) & (Kg) Table 54. Global Recombinant Human BMP-2 Sales Market Share by Application (2021-2026) Table 55. Global Recombinant Human BMP-2 Sales Market Share by Application (2027-2032) Table 56. Global Recombinant Human BMP-2 Price by Application (2021-2026) & (US$/g) Table 57. Global Recombinant Human BMP-2 Price by Application (2027-2032) & (US$/g) Table 58. 赛默飞世尔 Company Information Table 59. 赛默飞世尔 Business Overview Table 60. 赛默飞世尔 Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 61. 赛默飞世尔 Recombinant Human BMP-2 Product Portfolio Table 62. 赛默飞世尔 Recent Development Table 63. Yeasen Biotechnology (Shanghai) Company Information Table 64. Yeasen Biotechnology (Shanghai) Business Overview Table 65. Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Product Portfolio Table 67. Yeasen Biotechnology (Shanghai) Recent Development Table 68. Yantai Zhenghai Bio-Tech Company Information Table 69. Yantai Zhenghai Bio-Tech Business Overview Table 70. Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Product Portfolio Table 72. Yantai Zhenghai Bio-Tech Recent Development Table 73. Abbkine Scientific Company Information Table 74. Abbkine Scientific Business Overview Table 75. Abbkine Scientific Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Abbkine Scientific Recombinant Human BMP-2 Product Portfolio Table 77. Abbkine Scientific Recent Development Table 78. WEIGAO Company Information Table 79. WEIGAO Business Overview Table 80. WEIGAO Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. WEIGAO Recombinant Human BMP-2 Product Portfolio Table 82. WEIGAO Recent Development Table 83. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information Table 84. Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview Table 85. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Product Portfolio Table 87. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Development Table 88. Shanghai NovoPro Company Information Table 89. Shanghai NovoPro Business Overview Table 90. Shanghai NovoPro Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. Shanghai NovoPro Recombinant Human BMP-2 Product Portfolio Table 92. Shanghai NovoPro Recent Development Table 93. HANGZHOU JIUYUAN GENE ENGINEERIN Company Information Table 94. HANGZHOU JIUYUAN GENE ENGINEERIN Business Overview Table 95. HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Product Portfolio Table 97. HANGZHOU JIUYUAN GENE ENGINEERIN Recent Development Table 98. Beijing Baiaolaibo Technology Company Information Table 99. Beijing Baiaolaibo Technology Business Overview Table 100. Beijing Baiaolaibo Technology Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. Beijing Baiaolaibo Technology Recombinant Human BMP-2 Product Portfolio Table 102. Beijing Baiaolaibo Technology Recent Development Table 103. STEMCELL Technologies Company Information Table 104. STEMCELL Technologies Business Overview Table 105. STEMCELL Technologies Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 106. STEMCELL Technologies Recombinant Human BMP-2 Product Portfolio Table 107. STEMCELL Technologies Recent Development Table 108. Sigma Aldrich Company Information Table 109. Sigma Aldrich Business Overview Table 110. Sigma Aldrich Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 111. Sigma Aldrich Recombinant Human BMP-2 Product Portfolio Table 112. Sigma Aldrich Recent Development Table 113. Proteintech Company Information Table 114. Proteintech Business Overview Table 115. Proteintech Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 116. Proteintech Recombinant Human BMP-2 Product Portfolio Table 117. Proteintech Recent Development Table 118. CUSABIO TECHNOLOGY Company Information Table 119. CUSABIO TECHNOLOGY Business Overview Table 120. CUSABIO TECHNOLOGY Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 121. CUSABIO TECHNOLOGY Recombinant Human BMP-2 Product Portfolio Table 122. CUSABIO TECHNOLOGY Recent Development Table 123. Cgbio Company Information Table 124. Cgbio Business Overview Table 125. Cgbio Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 126. Cgbio Recombinant Human BMP-2 Product Portfolio Table 127. Cgbio Recent Development Table 128. Cell Guidance Systems Company Information Table 129. Cell Guidance Systems Business Overview Table 130. Cell Guidance Systems Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 131. Cell Guidance Systems Recombinant Human BMP-2 Product Portfolio Table 132. Cell Guidance Systems Recent Development Table 133. Biomol GmbH Company Information Table 134. Biomol GmbH Business Overview Table 135. Biomol GmbH Recombinant Human BMP-2 Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 136. Biomol GmbH Recombinant Human BMP-2 Product Portfolio Table 137. Biomol GmbH Recent Development Table 138. North America Recombinant Human BMP-2 Revenue by Type (2021-2026) & (US$ Million) Table 139. North America Recombinant Human BMP-2 Revenue by Type (2027-2032) & (US$ Million) Table 140. North America Recombinant Human BMP-2 Sales by Type (2021-2026) & (Kg) Table 141. North America Recombinant Human BMP-2 Sales by Type (2027-2032) & (Kg) Table 142. North America Recombinant Human BMP-2 Sales Price by Type (2021-2026) & (US$/g) Table 143. North America Recombinant Human BMP-2 Sales Price by Type (2027-2032) & (US$/g) Table 144. North America Recombinant Human BMP-2 Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Recombinant Human BMP-2 Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Recombinant Human BMP-2 Sales by Application (2021-2026) & (Kg) Table 147. North America Recombinant Human BMP-2 Sales by Application (2027-2032) & (Kg) Table 148. North America Recombinant Human BMP-2 Sales Price by Application (2021-2026) & (US$/g) Table 149. North America Recombinant Human BMP-2 Sales Price by Application (2027-2032) & (US$/g) Table 150. North America Recombinant Human BMP-2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. North America Recombinant Human BMP-2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. North America Recombinant Human BMP-2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. North America Recombinant Human BMP-2 Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 154. North America Recombinant Human BMP-2 Sales by Country (2021-2026) & (Kg) Table 155. North America Recombinant Human BMP-2 Sales by Country (2027-2032) & (Kg) Table 156. North America Recombinant Human BMP-2 Sales Price by Country (2021-2026) & (US$/g) Table 157. North America Recombinant Human BMP-2 Sales Price by Country (2027-2032) & (US$/g) Table 158. United States Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 159. Canada Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 160. Mexico Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 161. Europe Recombinant Human BMP-2 Revenue by Type (2021-2026) & (US$ Million) Table 162. Europe Recombinant Human BMP-2 Revenue by Type (2027-2032) & (US$ Million) Table 163. Europe Recombinant Human BMP-2 Sales by Type (2021-2026) & (Kg) Table 164. Europe Recombinant Human BMP-2 Sales by Type (2027-2032) & (Kg) Table 165. Europe Recombinant Human BMP-2 Sales Price by Type (2021-2026) & (US$/g) Table 166. Europe Recombinant Human BMP-2 Sales Price by Type (2027-2032) & (US$/g) Table 167. Europe Recombinant Human BMP-2 Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Recombinant Human BMP-2 Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Recombinant Human BMP-2 Sales by Application (2021-2026) & (Kg) Table 170. Europe Recombinant Human BMP-2 Sales by Application (2027-2032) & (Kg) Table 171. Europe Recombinant Human BMP-2 Sales Price by Application (2021-2026) & (US$/g) Table 172. Europe Recombinant Human BMP-2 Sales Price by Application (2027-2032) & (US$/g) Table 173. Europe Recombinant Human BMP-2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Europe Recombinant Human BMP-2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Europe Recombinant Human BMP-2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Europe Recombinant Human BMP-2 Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 177. Europe Recombinant Human BMP-2 Sales by Country (2021-2026) & (Kg) Table 178. Europe Recombinant Human BMP-2 Sales by Country (2027-2032) & (Kg) Table 179. Europe Recombinant Human BMP-2 Sales Price by Country (2021-2026) & (US$/g) Table 180. Europe Recombinant Human BMP-2 Sales Price by Country (2027-2032) & (US$/g) Table 181. Germany Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 182. France Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 183. U.K. Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 184. Italy Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 185. Russia Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 186. Spain Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 187. Netherlands Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 188. Switzerland Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 189. Sweden Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 190. Poland Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 191. China Recombinant Human BMP-2 Revenue by Type (2021-2026) & (US$ Million) Table 192. China Recombinant Human BMP-2 Revenue by Type (2027-2032) & (US$ Million) Table 193. China Recombinant Human BMP-2 Sales by Type (2021-2026) & (Kg) Table 194. China Recombinant Human BMP-2 Sales by Type (2027-2032) & (Kg) Table 195. China Recombinant Human BMP-2 Sales Price by Type (2021-2026) & (US$/g) Table 196. China Recombinant Human BMP-2 Sales Price by Type (2027-2032) & (US$/g) Table 197. China Recombinant Human BMP-2 Revenue by Application (2021-2026) & (US$ Million) Table 198. China Recombinant Human BMP-2 Revenue by Application (2027-2032) & (US$ Million) Table 199. China Recombinant Human BMP-2 Sales by Application (2021-2026) & (Kg) Table 200. China Recombinant Human BMP-2 Sales by Application (2027-2032) & (Kg) Table 201. China Recombinant Human BMP-2 Sales Price by Application (2021-2026) & (US$/g) Table 202. China Recombinant Human BMP-2 Sales Price by Application (2027-2032) & (US$/g) Table 203. Asia Recombinant Human BMP-2 Revenue by Type (2021-2026) & (US$ Million) Table 204. Asia Recombinant Human BMP-2 Revenue by Type (2027-2032) & (US$ Million) Table 205. Asia Recombinant Human BMP-2 Sales by Type (2021-2026) & (Kg) Table 206. Asia Recombinant Human BMP-2 Sales by Type (2027-2032) & (Kg) Table 207. Asia Recombinant Human BMP-2 Sales Price by Type (2021-2026) & (US$/g) Table 208. Asia Recombinant Human BMP-2 Sales Price by Type (2027-2032) & (US$/g) Table 209. Asia Recombinant Human BMP-2 Revenue by Application (2021-2026) & (US$ Million) Table 210. Asia Recombinant Human BMP-2 Revenue by Application (2027-2032) & (US$ Million) Table 211. Asia Recombinant Human BMP-2 Sales by Application (2021-2026) & (Kg) Table 212. Asia Recombinant Human BMP-2 Sales by Application (2027-2032) & (Kg) Table 213. Asia Recombinant Human BMP-2 Sales Price by Application (2021-2026) & (US$/g) Table 214. Asia Recombinant Human BMP-2 Sales Price by Application (2027-2032) & (US$/g) Table 215. Asia Recombinant Human BMP-2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. Asia Recombinant Human BMP-2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. Asia Recombinant Human BMP-2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. Asia Recombinant Human BMP-2 Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 219. Asia Recombinant Human BMP-2 Sales by Country (2021-2026) & (Kg) Table 220. Asia Recombinant Human BMP-2 Sales by Country (2027-2032) & (Kg) Table 221. Asia Recombinant Human BMP-2 Sales Price by Country (2021-2026) & (US$/g) Table 222. Asia Recombinant Human BMP-2 Sales Price by Country (2027-2032) & (US$/g) Table 223. Japan Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 224. South Korea Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 225. India Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 226. Australia Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 227. Taiwan Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 228. Southeast Asia Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 229. SAMEA Recombinant Human BMP-2 Revenue by Type (2021-2026) & (US$ Million) Table 230. SAMEA Recombinant Human BMP-2 Revenue by Type (2027-2032) & (US$ Million) Table 231. SAMEA Recombinant Human BMP-2 Sales by Type (2021-2026) & (Kg) Table 232. SAMEA Recombinant Human BMP-2 Sales by Type (2027-2032) & (Kg) Table 233. SAMEA Recombinant Human BMP-2 Sales Price by Type (2021-2026) & (US$/g) Table 234. SAMEA Recombinant Human BMP-2 Sales Price by Type (2027-2032) & (US$/g) Table 235. SAMEA Recombinant Human BMP-2 Revenue by Application (2021-2026) & (US$ Million) Table 236. SAMEA Recombinant Human BMP-2 Revenue by Application (2027-2032) & (US$ Million) Table 237. SAMEA Recombinant Human BMP-2 Sales by Application (2021-2026) & (Kg) Table 238. SAMEA Recombinant Human BMP-2 Sales by Application (2027-2032) & (Kg) Table 239. SAMEA Recombinant Human BMP-2 Sales Price by Application (2021-2026) & (US$/g) Table 240. SAMEA Recombinant Human BMP-2 Sales Price by Application (2027-2032) & (US$/g) Table 241. SAMEA Recombinant Human BMP-2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. SAMEA Recombinant Human BMP-2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 243. SAMEA Recombinant Human BMP-2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 244. SAMEA Recombinant Human BMP-2 Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 245. SAMEA Recombinant Human BMP-2 Sales by Country (2021-2026) & (Kg) Table 246. SAMEA Recombinant Human BMP-2 Sales by Country (2027-2032) & (Kg) Table 247. SAMEA Recombinant Human BMP-2 Sales Price by Country (2021-2026) & (US$/g) Table 248. SAMEA Recombinant Human BMP-2 Sales Price by Country (2027-2032) & (US$/g) Table 249. Brazil Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 250. Argentina Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 251. Chile Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 252. Colombia Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 253. Peru Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 254. Saudi Arabia Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 255. Israel Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 256. UAE Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 257. Turkey Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 258. Iran Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 259. Egypt Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Table 260. Key Raw Materials Table 261. Raw Materials Key Suppliers Table 262. Recombinant Human BMP-2 Distributors List Table 263. Recombinant Human BMP-2 Customers List Table 264. Research Programs/Design for This Report Table 265. Authors List of This Report Table 266. Secondary Sources Table 267. Primary Sources List of Figures Figure 1. Recombinant Human BMP-2 Image Figure 2. Global Recombinant Human BMP-2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human BMP-2 Market Size Share 2021 VS 2025 VS 2032 Figure 4. Powder Image Figure 5. Sponge Image Figure 6. Others Image Figure 7. Global Recombinant Human BMP-2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Recombinant Human BMP-2 Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Research Institute Image Figure 11. Others Image Figure 12. Global Recombinant Human BMP-2 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Recombinant Human BMP-2 Revenue (2021-2032) & (US$ Million) Figure 14. Global Recombinant Human BMP-2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Recombinant Human BMP-2 Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Recombinant Human BMP-2 Revenue Market Share by Region (2021-2032) Figure 17. Global Recombinant Human BMP-2 Sales (2021-2032) & (Kg) Figure 18. Global Recombinant Human BMP-2 Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 19. Global Recombinant Human BMP-2 Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Recombinant Human BMP-2 Sales YoY (2021-2032) & (Kg) Figure 21. Europe Recombinant Human BMP-2 Sales YoY (2021-2032) & (Kg) Figure 22. China Recombinant Human BMP-2 Sales YoY (2021-2032) & (Kg) Figure 23. Asia (Excluding China) Recombinant Human BMP-2 Sales YoY (2021-2032) & (Kg) Figure 24. South America, Middle East and Africa Recombinant Human BMP-2 Sales YoY (2021-2032) & (Kg) Figure 25. Global Recombinant Human BMP-2 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Recombinant Human BMP-2 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Recombinant Human BMP-2 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Recombinant Human BMP-2 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Recombinant Human BMP-2 Revenue Market Share by Type (2021-2032) Figure 31. Global Recombinant Human BMP-2 Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 32. Global Recombinant Human BMP-2 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Recombinant Human BMP-2 Sales Market Share by Type (2021-2032) Figure 34. Global Recombinant Human BMP-2 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Recombinant Human BMP-2 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Recombinant Human BMP-2 Revenue Market Share by Application (2021-2032) Figure 37. Global Recombinant Human BMP-2 Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 38. Global Recombinant Human BMP-2 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Recombinant Human BMP-2 Sales Market Share by Application (2021-2032) Figure 40. North America Recombinant Human BMP-2 Revenue Share by Type (2021-2032) Figure 41. North America Recombinant Human BMP-2 Sales Share by Type (2021-2032) Figure 42. North America Recombinant Human BMP-2 Revenue Share by Application (2021-2032) Figure 43. North America Recombinant Human BMP-2 Sales Share by Application (2021-2032) Figure 44. North America Recombinant Human BMP-2 Revenue Share by Country (2021-2032) Figure 45. North America Recombinant Human BMP-2 Sales Share by Country (2021-2032) Figure 46. Europe Recombinant Human BMP-2 Revenue Share by Type (2021-2032) Figure 47. Europe Recombinant Human BMP-2 Sales Share by Type (2021-2032) Figure 48. Europe Recombinant Human BMP-2 Revenue Share by Application (2021-2032) Figure 49. Europe Recombinant Human BMP-2 Sales Share by Application (2021-2032) Figure 50. Europe Recombinant Human BMP-2 Revenue Share by Country (2021-2032) Figure 51. Europe Recombinant Human BMP-2 Sales Share by Country (2021-2032) Figure 52. China Recombinant Human BMP-2 Revenue Share by Type (2021-2032) Figure 53. China Recombinant Human BMP-2 Sales Share by Type (2021-2032) Figure 54. China Recombinant Human BMP-2 Revenue Share by Application (2021-2032) Figure 55. China Recombinant Human BMP-2 Sales Share by Application (2021-2032) Figure 56. Asia Recombinant Human BMP-2 Revenue Share by Type (2021-2032) Figure 57. Asia Recombinant Human BMP-2 Sales Share by Type (2021-2032) Figure 58. Asia Recombinant Human BMP-2 Revenue Share by Application (2021-2032) Figure 59. Asia Recombinant Human BMP-2 Sales Share by Application (2021-2032) Figure 60. Asia Recombinant Human BMP-2 Revenue Share by Country (2021-2032) Figure 61. Asia Recombinant Human BMP-2 Sales Share by Country (2021-2032) Figure 62. SAMEA Recombinant Human BMP-2 Revenue Share by Type (2021-2032) Figure 63. SAMEA Recombinant Human BMP-2 Sales Share by Type (2021-2032) Figure 64. SAMEA Recombinant Human BMP-2 Revenue Share by Application (2021-2032) Figure 65. SAMEA Recombinant Human BMP-2 Sales Share by Application (2021-2032) Figure 66. SAMEA Recombinant Human BMP-2 Revenue Share by Country (2021-2032) Figure 67. SAMEA Recombinant Human BMP-2 Sales Share by Country (2021-2032) Figure 68. Recombinant Human BMP-2 Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Recombinant Human BMP-2 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Sponge
  • Others
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • 赛默飞世尔
  • Yeasen Biotechnology (Shanghai)
  • Yantai Zhenghai Bio-Tech
  • Abbkine Scientific
  • WEIGAO
  • Shanghai Zhong Qiao Xin Zhou Biotechnology
  • Shanghai NovoPro
  • HANGZHOU JIUYUAN GENE ENGINEERIN
  • Beijing Baiaolaibo Technology
  • STEMCELL Technologies
  • Sigma Aldrich
  • Proteintech
  • CUSABIO TECHNOLOGY
  • Cgbio
  • Cell Guidance Systems
  • Biomol GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Human BMP-2 Market by Type
  3. 1.2.1 Global Recombinant Human BMP-2 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Powder
  5. 1.2.3 Sponge
  6. 1.2.4 Others
  7. 1.3 Recombinant Human BMP-2 Market by Application
  8. 1.3.1 Global Recombinant Human BMP-2 Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Research Institute
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Recombinant Human BMP-2 Market Dynamics
  1. 2.1 Recombinant Human BMP-2 Industry Trends
  2. 2.2 Recombinant Human BMP-2 Industry Drivers
  3. 2.3 Recombinant Human BMP-2 Industry Opportunities and Challenges
  4. 2.4 Recombinant Human BMP-2 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Recombinant Human BMP-2 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Recombinant Human BMP-2 Revenue by Region
  3. 3.2.1 Global Recombinant Human BMP-2 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Human BMP-2 Revenue by Region (2021-2026)
  5. 3.2.3 Global Recombinant Human BMP-2 Revenue by Region (2027-2032)
  6. 3.2.4 Global Recombinant Human BMP-2 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Recombinant Human BMP-2 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Recombinant Human BMP-2 Sales by Region
  9. 3.4.1 Global Recombinant Human BMP-2 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Recombinant Human BMP-2 Sales by Region (2021-2026)
  11. 3.4.3 Global Recombinant Human BMP-2 Sales by Region (2027-2032)
  12. 3.4.4 Global Recombinant Human BMP-2 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Recombinant Human BMP-2 Revenue by Manufacturers
  2. 4.1.1 Global Recombinant Human BMP-2 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Recombinant Human BMP-2 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Recombinant Human BMP-2 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Human BMP-2 Sales by Manufacturers
  6. 4.2.1 Global Recombinant Human BMP-2 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Recombinant Human BMP-2 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Recombinant Human BMP-2 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Recombinant Human BMP-2 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Recombinant Human BMP-2 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Recombinant Human BMP-2 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Recombinant Human BMP-2 Manufacturers, Product Type & Application
  13. 4.7 Global Recombinant Human BMP-2 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Recombinant Human BMP-2 Market CR5 and HHI
  16. 4.8.2 2025 Recombinant Human BMP-2 Tier 1, Tier 2, and Tier 3
5 Recombinant Human BMP-2 Market by Type
  1. 5.1 Global Recombinant Human BMP-2 Revenue by Type
  2. 5.1.1 Global Recombinant Human BMP-2 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Recombinant Human BMP-2 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Recombinant Human BMP-2 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Recombinant Human BMP-2 Sales by Type
  6. 5.2.1 Global Recombinant Human BMP-2 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Human BMP-2 Sales by Type (2021-2032) & (Kg)
  8. 5.2.3 Global Recombinant Human BMP-2 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Recombinant Human BMP-2 Price by Type
6 Recombinant Human BMP-2 Market by Application
  1. 6.1 Global Recombinant Human BMP-2 Revenue by Application
  2. 6.1.1 Global Recombinant Human BMP-2 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Recombinant Human BMP-2 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Recombinant Human BMP-2 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Recombinant Human BMP-2 Sales by Application
  6. 6.2.1 Global Recombinant Human BMP-2 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Recombinant Human BMP-2 Sales by Application (2021-2032) & (Kg)
  8. 6.2.3 Global Recombinant Human BMP-2 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Recombinant Human BMP-2 Price by Application
7 Company Profiles
  1. 7.1 赛默飞世尔
  2. 7.1.1 赛默飞世尔 Company Information
  3. 7.1.2 赛默飞世尔 Business Overview
  4. 7.1.3 赛默飞世尔 Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 赛默飞世尔 Recombinant Human BMP-2 Product Portfolio
  6. 7.1.5 赛默飞世尔 Recent Developments
  7. 7.2 Yeasen Biotechnology (Shanghai)
  8. 7.2.1 Yeasen Biotechnology (Shanghai) Company Information
  9. 7.2.2 Yeasen Biotechnology (Shanghai) Business Overview
  10. 7.2.3 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Product Portfolio
  12. 7.2.5 Yeasen Biotechnology (Shanghai) Recent Developments
  13. 7.3 Yantai Zhenghai Bio-Tech
  14. 7.3.1 Yantai Zhenghai Bio-Tech Company Information
  15. 7.3.2 Yantai Zhenghai Bio-Tech Business Overview
  16. 7.3.3 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Product Portfolio
  18. 7.3.5 Yantai Zhenghai Bio-Tech Recent Developments
  19. 7.4 Abbkine Scientific
  20. 7.4.1 Abbkine Scientific Company Information
  21. 7.4.2 Abbkine Scientific Business Overview
  22. 7.4.3 Abbkine Scientific Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Abbkine Scientific Recombinant Human BMP-2 Product Portfolio
  24. 7.4.5 Abbkine Scientific Recent Developments
  25. 7.5 WEIGAO
  26. 7.5.1 WEIGAO Company Information
  27. 7.5.2 WEIGAO Business Overview
  28. 7.5.3 WEIGAO Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 WEIGAO Recombinant Human BMP-2 Product Portfolio
  30. 7.5.5 WEIGAO Recent Developments
  31. 7.6 Shanghai Zhong Qiao Xin Zhou Biotechnology
  32. 7.6.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
  33. 7.6.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
  34. 7.6.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Product Portfolio
  36. 7.6.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments
  37. 7.7 Shanghai NovoPro
  38. 7.7.1 Shanghai NovoPro Company Information
  39. 7.7.2 Shanghai NovoPro Business Overview
  40. 7.7.3 Shanghai NovoPro Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shanghai NovoPro Recombinant Human BMP-2 Product Portfolio
  42. 7.7.5 Shanghai NovoPro Recent Developments
  43. 7.8 HANGZHOU JIUYUAN GENE ENGINEERIN
  44. 7.8.1 HANGZHOU JIUYUAN GENE ENGINEERIN Company Information
  45. 7.8.2 HANGZHOU JIUYUAN GENE ENGINEERIN Business Overview
  46. 7.8.3 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Product Portfolio
  48. 7.8.5 HANGZHOU JIUYUAN GENE ENGINEERIN Recent Developments
  49. 7.9 Beijing Baiaolaibo Technology
  50. 7.9.1 Beijing Baiaolaibo Technology Company Information
  51. 7.9.2 Beijing Baiaolaibo Technology Business Overview
  52. 7.9.3 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Product Portfolio
  54. 7.9.5 Beijing Baiaolaibo Technology Recent Developments
  55. 7.10 STEMCELL Technologies
  56. 7.10.1 STEMCELL Technologies Company Information
  57. 7.10.2 STEMCELL Technologies Business Overview
  58. 7.10.3 STEMCELL Technologies Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 STEMCELL Technologies Recombinant Human BMP-2 Product Portfolio
  60. 7.10.5 STEMCELL Technologies Recent Developments
  61. 7.11 Sigma Aldrich
  62. 7.11.1 Sigma Aldrich Company Information
  63. 7.11.2 Sigma Aldrich Business Overview
  64. 7.11.3 Sigma Aldrich Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sigma Aldrich Recombinant Human BMP-2 Product Portfolio
  66. 7.11.5 Sigma Aldrich Recent Developments
  67. 7.12 Proteintech
  68. 7.12.1 Proteintech Company Information
  69. 7.12.2 Proteintech Business Overview
  70. 7.12.3 Proteintech Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Proteintech Recombinant Human BMP-2 Product Portfolio
  72. 7.12.5 Proteintech Recent Developments
  73. 7.13 CUSABIO TECHNOLOGY
  74. 7.13.1 CUSABIO TECHNOLOGY Company Information
  75. 7.13.2 CUSABIO TECHNOLOGY Business Overview
  76. 7.13.3 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Product Portfolio
  78. 7.13.5 CUSABIO TECHNOLOGY Recent Developments
  79. 7.14 Cgbio
  80. 7.14.1 Cgbio Company Information
  81. 7.14.2 Cgbio Business Overview
  82. 7.14.3 Cgbio Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Cgbio Recombinant Human BMP-2 Product Portfolio
  84. 7.14.5 Cgbio Recent Developments
  85. 7.15 Cell Guidance Systems
  86. 7.15.1 Cell Guidance Systems Company Information
  87. 7.15.2 Cell Guidance Systems Business Overview
  88. 7.15.3 Cell Guidance Systems Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Cell Guidance Systems Recombinant Human BMP-2 Product Portfolio
  90. 7.15.5 Cell Guidance Systems Recent Developments
  91. 7.16 Biomol GmbH
  92. 7.16.1 Biomol GmbH Company Information
  93. 7.16.2 Biomol GmbH Business Overview
  94. 7.16.3 Biomol GmbH Recombinant Human BMP-2 Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Biomol GmbH Recombinant Human BMP-2 Product Portfolio
  96. 7.16.5 Biomol GmbH Recent Developments
8 North America
  1. 8.1 North America Recombinant Human BMP-2 Market Size by Type
  2. 8.1.1 North America Recombinant Human BMP-2 Revenue by Type (2021-2032)
  3. 8.1.2 North America Recombinant Human BMP-2 Sales by Type (2021-2032)
  4. 8.1.3 North America Recombinant Human BMP-2 Price by Type (2021-2032)
  5. 8.2 North America Recombinant Human BMP-2 Market Size by Application
  6. 8.2.1 North America Recombinant Human BMP-2 Revenue by Application (2021-2032)
  7. 8.2.2 North America Recombinant Human BMP-2 Sales by Application (2021-2032)
  8. 8.2.3 North America Recombinant Human BMP-2 Price by Application (2021-2032)
  9. 8.3 North America Recombinant Human BMP-2 Market Size by Country
  10. 8.3.1 North America Recombinant Human BMP-2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Recombinant Human BMP-2 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Recombinant Human BMP-2 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Recombinant Human BMP-2 Market Size by Type
  2. 9.1.1 Europe Recombinant Human BMP-2 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Recombinant Human BMP-2 Sales by Type (2021-2032)
  4. 9.1.3 Europe Recombinant Human BMP-2 Price by Type (2021-2032)
  5. 9.2 Europe Recombinant Human BMP-2 Market Size by Application
  6. 9.2.1 Europe Recombinant Human BMP-2 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Recombinant Human BMP-2 Sales by Application (2021-2032)
  8. 9.2.3 Europe Recombinant Human BMP-2 Price by Application (2021-2032)
  9. 9.3 Europe Recombinant Human BMP-2 Market Size by Country
  10. 9.3.1 Europe Recombinant Human BMP-2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Recombinant Human BMP-2 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Recombinant Human BMP-2 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Recombinant Human BMP-2 Market Size by Type
  2. 10.1.1 China Recombinant Human BMP-2 Revenue by Type (2021-2032)
  3. 10.1.2 China Recombinant Human BMP-2 Sales by Type (2021-2032)
  4. 10.1.3 China Recombinant Human BMP-2 Price by Type (2021-2032)
  5. 10.2 China Recombinant Human BMP-2 Market Size by Application
  6. 10.2.1 China Recombinant Human BMP-2 Revenue by Application (2021-2032)
  7. 10.2.2 China Recombinant Human BMP-2 Sales by Application (2021-2032)
  8. 10.2.3 China Recombinant Human BMP-2 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Human BMP-2 Market Size by Type
  2. 11.1.1 Asia Recombinant Human BMP-2 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Recombinant Human BMP-2 Sales by Type (2021-2032)
  4. 11.1.3 Asia Recombinant Human BMP-2 Price by Type (2021-2032)
  5. 11.2 Asia Recombinant Human BMP-2 Market Size by Application
  6. 11.2.1 Asia Recombinant Human BMP-2 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Recombinant Human BMP-2 Sales by Application (2021-2032)
  8. 11.2.3 Asia Recombinant Human BMP-2 Price by Application (2021-2032)
  9. 11.3 Asia Recombinant Human BMP-2 Market Size by Country
  10. 11.3.1 Asia Recombinant Human BMP-2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Recombinant Human BMP-2 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Recombinant Human BMP-2 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Human BMP-2 Market Size by Type
  2. 12.1.1 SAMEA Recombinant Human BMP-2 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Recombinant Human BMP-2 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Recombinant Human BMP-2 Price by Type (2021-2032)
  5. 12.2 SAMEA Recombinant Human BMP-2 Market Size by Application
  6. 12.2.1 SAMEA Recombinant Human BMP-2 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Recombinant Human BMP-2 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Recombinant Human BMP-2 Price by Application (2021-2032)
  9. 12.3 SAMEA Recombinant Human BMP-2 Market Size by Country
  10. 12.3.1 SAMEA Recombinant Human BMP-2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Recombinant Human BMP-2 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Recombinant Human BMP-2 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Recombinant Human BMP-2 Value Chain Analysis
  2. 13.1.1 Recombinant Human BMP-2 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Recombinant Human BMP-2 Production Mode & Process
  6. 13.2 Recombinant Human BMP-2 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Recombinant Human BMP-2 Distributors
  9. 13.2.3 Recombinant Human BMP-2 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst